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SHARP, PENNY CUNNINGHAM, Ed.D. An Educational Program in Breast 
Cancer Screening for First-degree Relatives of Breast Cancer Patients. (1990) 
Directed by Dr. Charles M. Achilles. 75 pp. 
The purpose of this study was to evaluate an educational program for 
asymptomatic first-degree female, adult relatives of breast cancer patients designed to 
increase their participation in breast cancer screening. Two hundred patients were 
enrolled in the study when they came for out-patient breast cancer treatment at 
Bowman Gray School of Medicine. Each participating patient supplied personal 
information on either a sister, daughter or mother which enabled contact through 
mail and telephone with the relative. The relatives were randomly assigned to either 
experimental or control group with 191 completing the study. A posttest only 
research design was employed. Each member of the experimental group received a 
packet of mailed information and a nurse's phone call, both encouraging screening, 
followed by a posttest questionnaire three months later. Breast self-exam (BSE), 
clinical breast exam (CBE), and mammography were explained and participation in 
screening encouraged. Women in the control group were given the posttest 
questionnaire 3 months after their relatives were enrolled in the project, followed by 
the intervention. The efficacy of the Health Belief Model (HBM) to predict 
screening participation was also assessed. 
The study participants consisted primarily of white, married, middle-class women 
with a mean educational level of 12.5 years. Most of the patients discovered their 
own breast lumps; 42% during BSE, 39% by accident. Almost half of the relatives do 
not have CBEs as recommended by the American Cancer Society (ACS), and over 
60% do not have mammograms as recommended. 
Difference of proportions test (chi-square) revealed that women in the 
experimental group were more likely to practice BSE (p < .05), but were not more 
likely to participate in CBE or mammography. Women did report changes in 
screening behaviors as a result of the program (26 for BSE, 13 for CBE, and 17 for 
mammogram). Knowledge of breast cancer was significantly higher for women in the 
experimental group (p < .05). The greatest predictor of breast screening behaviors 
was the HBM, followed by subjects' income. 
An educational program can increase participation in breast self-exam and 
knowledge of breast cancer. 
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CHAPTER I 
INTRODUCfiON 
Breast Cancer Screening 1 
One of the major economic problems in the United States concerns the 
rising cost of medical care. As costs rise, it becomes apparent that the move 
toward cost containment will grow and that mass screening programs designed to 
screen generally healthy people will be curtailed. As a result, it has been 
recommended that screening activities be focused toward high risk groups in order 
to show more cost benefits (Jensen, 1982). Within this context, health education 
programs designed specifically for a high risk population should be implemented 
and evaluated in terms of both effectiveness and cost. Some diseases or 
conditions have both well-defined high risk groups and good prognoses if detected 
early and treated properly. One such disease is breast cancer (Wright, 1986). 
Significance 
One of the leading causes of morbidity and mortality among American women 
is breast cancer. It is the most commonly occurring cancer in women and is the 
leading cause of cancer death among women. An estimated one out of ten 
women in this country will develop breast cancer and in 1989, approximately 
142,900 new cases will be diagnosed and 43,300 women will die of the disease 
(American Cancer Society or ACS, 1989; Carter, Jones, Schatzkin & Brinton, 
1989). 
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While many risk factors for cancer of the breast have been identified, a 
positive family history is one of the strongest. The risk for a woman with a 
positive family history of premenopausally diagnosed breast cancer in a 
first-degree relative (sister, mother or daughter) is two to three times that of a 
woman of the same age in the general population with no family history of breast 
cancer (Helmrich, et al., 1983; Kelsey, 1979; Kelsey, Hildreth & Thompson, 1983; 
McLellan, 1988). The risk is greater if the first-degree relative had bilateral breast 
cancer (Bachman, 1988). 
Although numerous factors influence survival rate after diagnosis, tumor stage 
at diagnosis is currently the most important documented prognostic factor 
(Hayward, Shapiro, Freeman, & Corey, 1988; Silvestrini, Diadone, DiFronzo, 
Morabito, Valagussa & Bonadonna, 1986). Therefore, early detection by 
aggressive screening has been recommended using breast self-examination (BSE), 
clinical breast examination (CBE) and mammography. 
There is evidence that women with family histories of breast cancer neither 
consider themselves to have an increased risk nor are they more likely to 
participate in screening than are women without a positive family history (Taylor 
and Billingham, 1988). There is also evidence that familial breast cancer patients 
respond more readily to treatment than do other breast cancer patients (Lynch 
and Lynch, 1981 ), thus providing these women with better prognoses with early 
detection. 
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This project addressed the issue of breast cancer screening for a group of 
women who are generally considered to be at high risk for the disease, who have a 
good prognosis for cure if the disease is detected at an early stage, but who are 
unlikely currently to be participating in screening activities. If successful, this 
project would provide a program which may increase the participation of high risk 
women in breast cancer screening activities and, therefore, theoretically would 
reduce the number of women who die from this disease. 
Conceptual Basis 
The conceptual basis for this study was: 
1. Epidemiology of breast cancer 
2. Breast cancer screening activities 
3. Program development, implementation, and evaluation. 
Purpose 
The purpose of this study was to design, implement and evaluate an 
educational program providing information to encourage participation in breast 
cancer screening for asymptomatic first-degree female, adult relatives of breast 
cancer patients. 
The Problem 
The problem was to determine if a program specifically designed to target 
women at high risk for breast cancer will increase their participation in screening 
activities when compared to a control group. 
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Hmotheses 
The following hypotheses were tested. Differences were considered significant 
if they reached or exceeded the p ~ .05 level of significance. 
H1: There would be significant differences between the experimental group 
and the control group with participation in breast self-examination, clinical breast 
examination, or mammography activities. 
H2: There would be significant differences between the experimental group 
and the control group in awareness and knowledge of breast cancer and breast 
cancer screening activities. 
Definitions 
For clarification, the following terms are defined as follows: 
1. Breast self-examination (BSE): an examination of all breast tissue as a 
woman examines her own breasts in a mirror and through palpation. 
2. Clinical breast examination (CBE): an examination of the breasts by a 
health professional, usually a physician or physician assistant. 
3. First-degree adult female relative: mother, sister or daughter 18 years 
of age or older. 
4. Mammography or mammogram: an x-ray examination of the breasts. 
Delimitations 
This study was delimited by two important factors. 
1. The study only included first-degree adult, female relatives of breast 
cancer patients in either the Radiation Therapy Qinic or the 
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Hematology/Oncology Clinic of the Bowman Gray School of Medicine 
of Wake Forest University. The relatives had to live within the 
catchment area of the Bowman Gray School of Medicine of Wake 
Forest University which includes parts of North and South Carolina, 
Virginia, Tennessee, and Georgia. 
2. Data were collected from the breast cancer patients through face-to-
face interviews and their relatives through telephone interviews. 
Relatives who could not be reached by telephone were not included in 
the study. 
Limitations 
This study was limited by three factors. 
1. The willingness of patients to provide the name, address and telephone 
number of a relative who met the study criteria. 
2. The accuracy of the self-reported data concerning breast cancer 
screening activities. 
3. The relatively short length of time (three months) between 
intervention and posttest interview. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
Epidemiology of Breast Cancer 
One out of every ten women in the United States is likely to develop breast 
cancer. It is one of the leading causes of morbidity and mortality and is the 
leading cause of cancer death among American women (ACS, 1980 & 1989; 
Carter, 1989). In 1989, approximately 43,300 women died of this disease (ACS, 
1989). In addition, breast cancer alone accounts for nearly 26% of all years of 
potential life lost before the age of 65 due to cancer (Mortality and Morbidity 
Weekly Report, 1987). The incidence of the disease is increasing progressively 
throughout the world and, while in the United States the incidence is one of the 
highest, it is still increasing, especially in women under the age of 40 (Humphrey 
&, Ballard, 1989). North Carolina ranks 26th in the United States in age-adjusted 
mortality rates from breast cancer in women, with 32 per 100,000 (Mortality and 
Morbidity Weekly Report, 1989). 
While there are well established risk factors for breast cancer, approximately 
75% of breast cancers occur in women with no known risks (Seidman, Stellman & 
Mushinski, 1982; Strax, 1987). It is, therefore, important to recognize that all 
women have the risk for developing this disease even though some are much more 
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vulnerable. There is clear evidence that both genetics and lifestyle choices may 
increase a woman's risk. 
Extensive study of the disease has resulted in labeling several variables as risk 
factors. Incidence of breast cancer increases with age, so that risk of the disease 
is six times higher at age 70 than at age 40 (Strax, 1977; Dupont & Page, 1985). 
Age at the time of certain milestones in a woman's life also appears to alter her 
risk. A relatively recent trend toward delayed childbirth increases risk (White, 
1987). Age greater than 30 years at first birth, or never having had a child, have 
both been associated with increased breast cancer risk (Lynch & Lynch, 1981; 
Dupont & Page, 1987; Blot, 1980; White, 1987; Schatzkin, 1987; Brinton, Hoover 
& Fraumeni, 1983; Carter, 1989; Helmrich, 1983). Early age at onset of 
menstruation or late natural menopause are also well documented risks 
(Humphrey, 1989; Lynch, 1981). 
Exposure to radiation (Shore, Hildreth, Woodard, et al., 1986; Boice & 
Monson, 1977), personal history of endometrial or ovarian cancer (Humphrey, 
1989), higher socioeconomic or educational status and Jewish heritage (Carter, 
1989; Helmrich, 1983) are all associated with higher risk of the disease. 
Factors related to diet which are associated with greater risk include even 
moderate alcohol consumption (Schatzkin, 1987; Willett, Stampfer, Colditz, 
Rosner, Hennekens & Speizer, 1987; O'Connell, Hulka, Chambless, Wilkinson & 
Deubner, 1987) and obesity and/or high fat in the diet (Lubin, Ruder, Wax, & 
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Modan, 1985; Schatzkin, 1987; Willett, Stampfer, Colditz, Rosner, Hennekens & 
Speizer, 1987; Lubin, Wax & Modan, 1986). 
The greatest known risk factor for breast cancer is a positive personal or 
family history of the disease (Humphrey, 1989; Dupont, 1987; Vakil, Morgan & 
Elinson, 1981; Carter, 1989; Anderson, 1972; Helmrich, 1983; Brinton, Hoover & 
Fraumeni, 1983; Lynch, 1981). The risk is higher for relatives with premenopausal 
diagnoses or if the disease was bilateral. If the disease is both premenopausal and 
bilateral, the relative risk is nine times that of women with negative family 
histories (Anderson, 1972; Leis, Greene, & Hilfer, 1986; Lynch, 1981). 
Although numerous factors influence survival rate after diagnosis, tumor stage 
at diagnosis is currently the most important documented prognostic factor 
(Harward, 1988; Silvestrini, 1986). Therefore, early detection by aggressive 
screening has been recommended, especially for women known to be at high risk 
(Wright, 1986). 
Screening is a procedure to detect undiagnosed disease in an asymptomatic 
individual (Strax, 1977). Aggressive screening programs reduce the probability of 
death from the disease by approximately 10 out of 10,000 (Eddy, 1989). Studies 
have shown that screening has a positive effect on reducing mortality (Shapiro, 
Venet, Strax, Venet & Roeser, 1982; Shapiro, 1977; United States Preventive 
Services Task Force or USPSTF, 1987). The methods of screening which are 
currently used for breast cancer are breast self- examination (BSE), clinical breast 
examination (CBE), and mammography. 
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Breast Self-Examination (BSE) 
Most breast cancers are found by women themselves and for this reason 
breast self-examination has been recommended as a low-cost, low-risk, 
self-screening method for detecting breast cancer at an early stage (Humphrey, 
1989). The goal in BSE is to find breast lumps at their smallest palpable size 
before the disease has progressed and when chances of cure are the highest. 
Despite published reports that BSE can lead to earlier diagnosis (Mant, Vessey, 
Neil, McPherson, Jones, 1987), whether or not this alone leads to improved 
mortality from breast cancer is unclear (United Kingdom Tiial of Early Detection 
of Breast Cancer Group, or UK li"ial, 1981 & 1988). 
Many researchers have attempted to evaluate the effectiveness of BSE with 
varying success. Two studies which have received a great deal of attent~on as 
controlled studies on the effectiveness of BSE are from the United Kingdom and 
the Soviet Union (UK Trial, 1981 & 1988; Semiglazov & Moiseenko, 1987). The 
Soviet Union study has enrolled 62,252 women into an experimental group (who 
receive instruction in BSE) and a control group to test the effectiveness of this 
screening modality on breast cancer mortality. Data should be available in 1990. 
In the UK study, 45,841 women were offered annual screening with clinical 
examination and mammography every other year; 63,636 women were offered 
BSE instruction and a self-referral clinic, and over 120,000 women were studied as 
a control group. After seven years, no difference in mortality has been observed 
between the group which was offered BSE instruction and the control group. 
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Cole and Austin (1981), in an evaluation of the data from BSE effectiveness 
studies, concluded that the benefits of BSE may be small for women who use 
clinical examination and mammography as recommended. However, it may be an 
important modality for early detection of breast cancer in women who do not use 
these services. 
Although most primary care physicians recommend BSE to their female 
patients (ACS, 1985), and 95% of the women in the United States know about 
BSE, only 27% report regular monthly BSE. Even among women with previously 
diagnosed breast cancer, only 43% practice BSE on a monthly basis (Holleb, 1979; 
McLellan, 1988). One reason for noncompli~nce with BSE may be the 
psychological cost to the woman when she has to face the issue each month that 
she is at risk for breast cancer (O'Malley & Fletcher, 1987). A second issue which 
has not been fully explored is the economic cost for evaluation of noncancerous 
breast lumps and the cost of teaching BSE in terms of personnel and time. The 
cost-effectiveness of BSE has not been clearly established. 
Lack of evidence supporting the use of BSE has lead the U.S. Preventive 
Services Task Force (USPSTF) to make no recommendations about the inclusion 
or exclusion of teaching BSE as a part of periodic health examinations (USPSTF, 
1987). The World Health Organization's (1984) statement on BSE is as follows: 
There is insufficient evidence that BSE as applied to date is effective in 
reducing mortality from breast cancer. Therefore, BSE screening 
programmes are not at present recommended as public health policy, 
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although there is equally insufficient evidence to change them where they 
already exist (p 867). 
However, the lack of definitive evidence that BSE is not effective, together 
with the potential benefit for women who are unlikely to routinely use the other 
screening methods (eg., due to cost, etc.) suggest that promotion of BSE can be a 
valuable component in a comprehensive educational program. The American 
Cancer Society recommends monthly BSE for all women over the age of 20 (ACS, 
1980). 
Clinical Breast Examination 
Clinical breast examination (CBE) alone has not been evaluated in a 
randomized controlled trial. However, descriptive studies support its effectiveness 
in detecting early stages of cancer and improving survival rates (Baker, 1982; 
Gilbertsen & Kjelsberg, 1971; Senie, Rosen, Lesser & Kinne, 1981). The Health 
Insurance Plan of Greater New York (HIP) utilized a randomized trial designed 
to evaluate the effectiveness of mammography and clinical examination to detect 
early breast cancer and reduce breast cancer mortality (Shapiro, 1977; Shwartz, 
1978). In this study, 45% of all breast cancers were detected by CBE alone, 33% 
by mammography, and 33% by both modalities. Further analyses revealed that a 
major portion of the combined 33% was due to the physical exam alone. The 
relative contribution of CBE and mammography varied with the patient's age. In 
women less than 50 years old, 61% of the tumors would have been missed with 
mammography alone and 19% would have been missed with CBE alone. In 
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women older than 50, mammography and CBE contributed equally to cancer 
detection. Similarly, in the Breast Cancer Detection Demonstration Project 
(BCDDP), 9% of all breast cancers missed by mammography were found on 
clinical examination (Baker, 1982). However, it is important to note that CBE is 
limited in that tumors must be of a certain size and consistency to be palpable. 
Most lumps less than 1 em in size will be missed on clinical examination (Fletcher, 
O'Malley & Bunce, 1985; Hicks, Davis, Layton, Present, 1979). The specificity of 
clinical breast examination in the BCDDP was 95% and the positive predictive 
value was 49%. 
Since evidence supports the effectiveness of CBE, it has been recommended 
annually for all women over the age of 40 and more frequently for women with 
histories of breast cancer, with histologically proven cystic breast disease, and with 
a family history of breast disease in a first-degree relative (ACS, 1980; Fletcher & 
O'Malley, 1986; Strauss, Solomon, Costanza, Worden & Foster, 1987; USPSTF, 
1987). The American Cancer Society recommends clinical examinations for 
women between the ages of 20 and 40 every 3 years (ACS, 1980). For women 
with family histories of premenopausally diagnosed breast cancer in a first-degree 
relative, the U.S. Preventive Services Task Force recommends CBE for women 
19 to 39 years of age. 
Mammography 
Several studies evaluating mammography as a screening tool for asymptomatic 
women have shown that it can reduce mortality from breast cancer. At 14 years 
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of follow-up, the Health Insurance Plan (HIP) study showed a 20% reduction in 
mortality among the study group (31,000 women) as compared to the similarly-
sized control group (Feig, 1988). Of the breast cancers detected in the screened 
women, one-third were detected by mammography only and of those, 79% had 
negative axillary nodes at surgery. In the control group, only 48% had negative 
axillary nodes at the time of surgery. Subsequent research has supported the 
results of the HIP study (Stevens, Moolgvkar, & Lee, 1982; Thbor & Dean, 1987). 
Based on the evidence that early detection of breast cancer is possible, annual 
screening with mammography and clinical examinations are recommended for 
women greater than 50 years old. The ACS recommends a baseline screening 
mammogram between the ages of 35 and 40 and biennial mammography after age 
40 (Humphrey, 1989). The U.S. Preventive Services Task Force recommends 
mammography for women, 19-39 years of age, who have a first-degree relative 
with premenopausally diagnosed breast cancer. It recommends mammograms 
every year or two for women beginning at age 50 until age 75, with annual CBEs 
starting at age 40 (USPSTF, 1987). 
Summazy 
Because tumor stage at diagnosis is the most important documented 
prognostic factor and all three modalities for early detection of breast tumors have 
been shown to be effective, this project encouraged women to participate in BSE, 
CBE and mammography. 
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Self-Report of Health Behaviors 
New studies on the validity of self-report~d health behaviors have revealed 
encouraging information. While the results of various inquiries into self-report 
have reported varying degrees of accuracy, there appears to be an agreement that 
self-report is a valid manner of collecting information (Strecher, Becker, Clark & 
Prasada-Rao, 1989; Bush, Miller, Golden & Hale, 1989; Cleary & Jette, 1984; 
Sawyer, Earp, Fletcher, Daye & Wynn, 1989; Baranowski, 1985; Paganini-Hill & 
Ross, 1982; Harlow & Linet, 1989; Bean, Leeper, Wallace, Sherman & Jagger, 
1989). This project relied on the accuracy of self-reported screening behaviors of 
the participants as the only means of data collection. 
Educational Intervention 
There have been many interventions designed to persuade women to 
participate in screening for breast cancer, especially BSE (Baker, 1982; Beaman, 
1988; Grady, Kegeles, Lund, Wolk & Farber, 1983) and some have been more 
effective than others. However, Gold (1964) found that relatives of breast cancer 
patients avoided recommended examinations and screening, intensely fearful that 
a malignant tumor would be found. Another study revealed that even after 
special education about the value of BSE, women with positive family histories for 
breast cancer were less likely to perfo~ monthly BSE than other women in the 
study (Worden, Costanza, Foster, Lang & Tidd, 1983). In contrast to these studies, 
however, Strauss, et al. (1987) found that women with personal histories of breast 
cancer were more likely to practice BSE regularly and that they perceived cancer 
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to be less threatening than did a control group of non-cancer patients. Bennett, et 
al. (1983) found that women with maternal histories of breast cancer were more 
likely to perform monthly BSE. 
This intervention was based on the Health Belief Model (HBM) which has 
been used as a theoretical model for other public health education programs 
specifically designed to encourage participation in BSE (Champion, 1985 & 1988; 
Hallal, 1982; McLellan, 1988). The HBM explains a person's likelihood of taking 
preventive action in terms of the perceived threat of the disease weighed against 
the perceived benefits and barriers to taking the action and the perceived ability 
of the individual to take the desired action. Theoretically, intervention at any point 
in the model may enhance the probability of the desired action (Rosenstock, 1974; 
Rosenstock, Strecher & Becker, 1988). 
While many different approaches have been used as means for increasing 
· participation in breast cancer screening, this approach was unique in that: (1) it 
focused on a specific high risk population [first-degree relatives of breast cancer 
patients] and, (2) it addressed cost as a factor by using nurses rather than 
physicians. 
The intervention was designed to encourage first-degree adult female relatives 
of breast cancer patients to participate in screening programs for breast cancer. 
It was both a time and cost-effective program in that the intervention used a 
research assistant and a nurse, rather than physicians, and materials were mailed 
to the participants. Contacts as part of the intervention and for posttest 
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interviews were by telephone. Similar programs (Beckie, 1989; lams, Johnson, 
O'Shaughnessy & West, 1987) have employed the use of telephone calls by nurses 
as part of the intervention quite successfully and cost-effectively (Bertera & 
Bertera, 1981), although difficulty in reaching the women by telephone has been 
noted as a constraint. 
Introduction 
CHAPTER III 
METHODOLOGY 
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The intervention was intended to encourage first-degree female relatives of 
breast cancer patients to participate in screening programs for breast cancer. The 
program was designed to be both time and cost-effective. Rather than physicians, 
the intervention utilized a research assistant and a nurse to contact patients, and 
materials were mailed to participants. Contact as part of the intervention and for 
posttest interviews was by telephone. 
Research Design 
The research design was a posttest only design. This approach allowed for 
randomization without the possible biases which might have been introduced by 
pretesting as shown in Figure 1. 
Figure 1. Posttest only research design 
Groups 
Experimental R 
Control R 
X 0 
0 X 
'R' = random assignment into either the experimental or control group 
'X' = intervention 
'0' = posttest interview 
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Since the most adequate all-purpose assurance of lack of initial biases is 
randomization, this design is particularly useful in educational research where 
pretests are impractical or likely to introduce biases (Campbell & Stanley, 1963). 
Subjects 
Subjects were first-degree female relatives of breast cancer patients. They 
included adult mothers, sisters, and daughters of patients who received medical 
care for breast cancer at the Bowman Gray School of Medicine. The initial 
contacts were consecutive adult patients in the Radiation Therapy Unit and the 
Hematology/Oncology Clinic of the Bowman Gray School of Medicine of Wake 
Forest University. During February and March, 1990, each breast cancer patient 
was asked to participate in the study. Those who agreed signed an informed 
consent form, and completed a short questionnaire (see Appendix A). The 
patients who agreed were asked to supply the name, address and telephone 
number of a first-degree female relative. Only adult relatives who lived in the 
catchment area of the medical school were eligible. The catchment area included 
parts of Georgia, North and South Carolina, Tennessee, and Virginia. Those 
patients unable to supply the name of a first-degree relative who lived within the 
study region were excluded from the study. The relatives were randomly assigned 
by computer-generated random number assignment to either intervention or 
control group. It was necessary to interview 301 breast cancer patients for the 
study in order to accrue the 200 patients required to complete the study. Eighty-
eight patients were ineligible because they did not have a relative who qualified 
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for the study. Only 13 patients refused to participate; 8 stated that they did not 
feel well enough to be interviewed, and 5 were not interested. 
Figure 2 presents a flow chart showing the plans for data collection from the 
experimental and control groups. 
Intervention 
Available printed· materials were reviewed by the principal investigator and, 
with the exception of a specific brochure designed to address the needs of breast 
cancer patients' relatives, no new materials were needed. One brochure 
developed specifically for this project highlighted the need for breast cancer 
screening activities by relatives of breast cancer patients. With the completion of 
this brochure, a packet of educational materials concerning breast cancer was 
assembled and mailed to each relative in the intervention group. The packet 
included: 
1. A letter explaining why the materials were being sent. 
2. National Cancer Institute pamphlet, "Breast Exams: What You Should 
Know" (NIH Publication No. 89-2000), which covers in detail all three 
methods of breast examinations. 
3. Pamphlet specifically designed by the principal investigator for relatives of 
breast cancer patients (Appendix C). 
In addition to the packet of materials, each woman in the experimental group 
was phoned by a Hematology/Oncology nurse who: (1) explained the project and 
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Figure 2. Flow chart of experimental design for the breast cancer education 
program for first-degree relatives, 1990. 
Patient identified 
& asked to participate 
Nr 
• 
~ge, race, reason 
for refusal noted 
I 
• Signs consent form & gives 
name, address & phone of 
eligible relative (see 
~ppendix ~) 
I 
I 
Relative randmrtly assigned to 
experimental o1 control group 
I • 
Control 
3 months after contact 
with cancer patient 
posttest questionnaire 
(see ~rpendix B) 
• 
Packet mailed to relative 
in control group (following 
posttejt questionnaire) 
• 
Phone call from Hematology/ 
Oncology nurse 
• 
Experimental 
I 
Packet maiTed to relative 
• Phone call from 
Hematology/Oncology nurse 
I 
• 
3 months after call from 
nurse, posttest questionnaire 
(see ~ppendix B) 
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answered any questions about the project; (2) encouraged participation in breast 
cancer screening; (3) answered any questions which the woman had about breast 
cancer. 
Data Collection 
The experimental group participants received the packet in the mail, followed 
by a phone call from the project nurse, and a second phone call from either the 
principal investigator or a research assistant three months after the nurse's call. 
The three month waiting period allowed time for the participant to: (1) make an 
appointment for a clinical breast examination and/or a mammogram; (2) make 
~rrangements to learn breast self-examination; or (3) continue .with the screening 
program that the participant was already practicing. The principal investigator or 
the research assistant explained the purpose of the project and encouraged the 
participants to participate in the evaluation. If they agreed, the questionnaire was 
administered over the phone. 
Data were coded and ten percent were recoded to assure accuracy. No 
mistakes were detected; therefore, no additional double-coding was required. All 
data were encoded and verified before analysis began. 
Measurement 
Demographic data were collected from both the patient and the participating 
relative in order to compare the study population with characteristics previously 
found to be associated with breast cancer. These data included age, race, marital 
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status, total household income the previous year, and education (last grade of 
school completed). 
Patients were questioned as to the history of their own breast cancer, 
including: (1) diagnosis before, during or after menopause; (2) how the breast 
cancer was discovered; (3) whether or not the patient had discussed her disease 
with the relative she named; ( 4) whether or not she thought that her relative 
participated in breast cancer screening; and, ( 5) family history of breast cancer. 
Relatives were asked similar questions concerning discussion of the patient's 
disease and whether or not the patient encouraged screening. 
Relatives in the experimental and control groups also were asked specific 
questions concerning participation in breast self-exam (BSE), clinical breast exam 
(CBE), and mammography in the past three months. Additional data were 
collected on each component of screening. Questions were asked concerning BSE 
class attendance, interest in a BSE class and whether or not the women felt that 
they were doing BSE correctly. Additional information on CBE included whether 
or not the relative ever had a CBE exam, whether the CBEs were within the 
schedule recommended by the American Cancer Society (ACS), interest in having 
another CBE in the future, and perceived difficulty in making and keeping an 
appointment for a CBE in the future. Similar questions were asked in regard to 
mammography. 
Relatives in the experime~tal group were asked additional questions 
concerning the impact of the program. Separate data were collected for each 
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screening technique. The women were asked two specific questions for each 
technique: (1) Have you done anything differently about (BSE. CBE. or 
mammography) as a result of either the packet of information you received from 
us or the nurse's phone call? (2) If yes, what? and If no, why not? 
Analysis Plan 
In order to examine the efficacy of the Health Belief Model (HBM) in 
predicting screening behaviors in this project, several questions were included in 
the data collection. In addition to the questions which focused on intended 
behaviors and barriers to screening, relatives were asked how concerned they were 
about breast cancer (perceived seriousness), how likely they thought it was that 
they might get breast cancer (perceived susceptibility) on Likert-type scales of 1 to 
5, and what percent of breast cancer can be cured if found early and treated 
correctly (perceived benefit of early diagnosis and treatment). A HBM score was 
computed by adding points for positive behaviors or perceptions, and subtracting 
for negative behaviors or perceptions. The scores ranged from -7 to + 7. 
Scores were constructed in order to test the second hypothesis concerning 
differences in awareness and knowledge between experimental and control groups. 
An awareness score was calculated by adding responses to questions on BSE 
(interest in attending a class in BSE), CBE (interest in having a future CBE), 
mammogram (interest in having a mammogram in the future), and concern about 
breast cancer. Response 3 (uncertain) was scored as zero for all questions and 
the total score was divided by 4 (total number of questions in the scale), for a 
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score which ranged from 1 to 5, with 5 indicating a high degree of awareness of 
breast cancer and need for screening. A knowledge score was calculated from 
responses to 2 questions on BSE (attendance in a BSE class and whether or not 
the woman felt she performed BSE correctly, both dichotomous variables), and 
the general question pertaining to percentage of breast cancer that can be cured. 
The responses to the general question were dichotomized at < 84% (recoded as 
incorrect) and~ 85% (recoded as correct, since the generally accepted correct 
answer to the question is 90% ). Scores ranged from 0-3, with 3 indicating higher 
degree of knowledge. 
Statistical analysis employed the difference of proportions test (chi-square) and 
the t-test. The basic test employed was the difference of proportions test between 
the experimental and control groups for the proportion of women who engage in 
breast cancer screening. 
In order to determine if there were any significant (p < .05) correlations 
between demographics, knowledge, awareness, the HBM, and screening behaviors, 
Pearson product-moment correlations were used. 
CHAPTER IV 
RESULTS 
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The results of the study are organized into two sections for presentation. The 
first section includes descriptive statistics, the second presents the results of the 
tests of the hypotheses. 
Demographics 
Demographic descriptors on patients and participating relatives are presented 
in Table 1. Frequencies and percentage distributions are shown for age 
(grouped), last year of school completed, marital status, race, total family income 
the previous year (1988-1989), time of diagnosis, how breast cancer was 
discovered, and if the patient discussed her breast cancer with the relative she 
named. 
The participants consisted primarily of white, married, middle-class women 
who had a mean education of 12 years. The majority of the patients had 
discovered their own breast lumps, with about even numbers finding it during 
breast self-exam (BSE) and by accident. Almost 19% of the women who 
discovered their own breast lumps did so because of another symptom, such as 
pain or a rash. About 25% of the cancers were discovered by either clinical 
breast exam (CBE) or mammography, while 1.5% were discovered by either a 
husband or lover. There was no clear distinction as to the time of diagnosis in 
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Thble 1. Characteristics of study participants. in breast cancer education program 
for first-degree relatives. 1990. 
Variable Patients Relatives 
Number Percent Number Percent 
Age 
< 39 years 23 11.5 72 36.0 
40-49 years 47 23.5 41 20.5 
50-59 years 60 30.0 27 13.5 
60-69 years 40 20.0 32 16.0 
> 70 years 30 15.0 18 9.0 
Unknown to• 5.0 
Total 200 100 200 100 
Education 
<8th grade 31 15.5 16 8.0 
9-11 th grades 19 9.5 23 11.5 
High School grad 85 42.5 71 35.5 
Some college/grad 48 24.0 77 38.5 
Post graduate 16 8.0 4 2.0 
Unknown 1 .5 9* 4.5 
Total 200 100 200 100 
Breast Cancer Screening 27 
Thble 1. (Continued) 
Variable Patients Relatives 
Number Percent Number Percent 
Marital Status 
Married 135 67.5 124 62.0 
Single 9 4.5 18 9.0 
Divorced 16 8.0 19 9.5 
Widowed 36 18.0 25 12.5 
Separated 4 2.0 5 2.5 
Unknown 9. 4.5 
Total 200 100 200 100 
Family Income 
< $14,999 62 31.0 43 21.5 
$15,000-24,999 38 19.0 43 21.5 
$25,000-34,999 18 9.0 31 15.5 
> $35,000 70 35.0 67 33.5 
Unknown 12 6.0 16. 8.0 
Total 200 100 200 100 
Race 
Black 16 8.0 NA NA 
White 184 92.0 
Total 200 100 
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Table 1. (Continued) 
Variable Patients Relatives 
Number Percent Number Percent 
Disease Related Variables 
Discussed Own Breast Cancer With Relative 
Yes 190 95.0 167 83.5 
No 10 5.0 23 11.5 
Unknown to• 5.0 
Total 200 100 200 100 
Time of Diagnosis 
Before menopause 79 39.5 NA NA 
During menopause 15 7.5 
After menopause 76 38.0 
Post hysterectomy 28 14.0 
Unknown 2 1.0 
Total 200 
How Breast Cancer Was Discovered 
Self 143 71.5 NA NA 
Accident (56) (39.2)** 
BSE (60) (42.0)** 
Other Symptom (27) (18.9)** 
Clinical Exam 17 8.5 
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Table 1. (Continued) 
Variable Patients Relative 
Number Percent Number Percent 
Mammogram 34 17.0 NA NA 
Husband/Lover 3 1.5 
Other 1 .5 
Unknown 2 1.0 
Total 200 100 
•- These numbers include those women who declined to participate in the study. 
** These numbers and percentages are for women who discovered the disease 
themselves. 
relationship to menopause, with equal numbers of diagnosis before and after 
menopause. Over eighty percent of the patients and relatives agreed that they 
had discussed the disease among themselves. In addition, the patients' years of 
survival since diagnosis ranged from 0 (newly diagnosed) to 26 years, with a mean 
of 4. 7 years, and S.D. of 5.34 years. 
Seventy percent of the relatives were practicing BSE; almost half were having 
clinical exams as recommended by the ACS, but only one-third were following the 
ACS recommendations for mammograms, as shown in Table 2. 
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Thble 2. Overall participation in screeninK by participants, 1990 study of breast 
cancer education for first-degree relatives. 
Did you participate in the following activities? 
Yes No 
Number Percent* 
BSE 141 
CBE 99 
Mammogram 68 
70.5 
49.5 
34.0 
Number Percent* 
49 
92 
123 
24.5 
49.5 
61.5 
* Percentages do not total 100 due to missing information 
Tests of the Hypotheses 
Two hypotheses were tested at the p < .05 level of significance: 
H 1: There would be significant differences between the experimental group 
and the control group with participation in breast self-examination, 
clinical breast examination or mammography. 
H2: There would be significant differences between the experimental group 
and the control group in awareness and knowledge of breast cancer 
screening. 
The first hypothesis was tested by examining self-reported answers to 
screening questions. The relatives were asked if they had done breast self-exam 
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(BSE) had a clinical breast exam, or had a mammogram in the last three months. 
If they had not had a clinical breast exam (CBE) or a mammogram within the 
past three months, they were asked if they had ever had either and, if so, how 
long ago. The answers were scored as having had a clinical exam and/or a 
mammogram within the time schedule recommended by the American Cancer 
Society. Comparisons of proportions of women in the experimental and control 
groups who participated in screening were made using chi-square analysis with the 
criterion for statistical significance at p < .05. 
The results of the test of the first hypothesis are shown in Table 3. 
Relatives in the experimental group were also asked whether anything had 
changed as a result of the program. Twenty-six women reported differences in 
Thble 3. Overall particination in breast cancer screening by group, 1990 study of 
breast cancer education for first-degree relatives. 
Experimental 
Variable 
BSE 79 (56.03%) 
CBE 50 (50.50%) 
Mammogram 31 (45.59%) 
* Significant at the p < .05 level 
Control 
62 (43.97%) 
49 (49.49%) 
37 (54.41%) 
7.04 
.00 
.49 
p 
.008* 
.940 
.483 
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breast self-exam, 13 reported differences in clinical exam, and 17 reported 
differences in mammogram. The 56 women who reported changes were then 
asked an open-ended question as to what changes had occurred. The responses 
are grouped in Table 4. 
The second hypothesis was tested by comparing knowledge and awareness 
scores about breast cancer and breast cancer screening for experimental and 
control group participants, using Student's t-test with the criterion for significance 
p < .05. Results of t-test are shown in Table 5. 
The efficacy of the Health Belief Model for predicting screening behavior in 
this population was examined. The HBM score which was computed by adding 
positive responses to questions concerning screening perceptions and intentions, 
and by subtracting responses for negative perceptions and intentions ranged from 
-7 to + 7. Results of the predictive value of the HBM in this study are presented 
in Table 6. 
Pearson product-movement correlations were used to examine the 
relationships between demographic data for the relative, the Health Belief Model, 
(scores -7 to + 7) and screening behaviors. Age and education were entered as 
continuous variables. Income was entered as the grouped variable shown in Table 
1 (page 28), while marital status was dichotomized as 'married' or 'not married'. 
'Behaviors' is a computed variable which adds 1 for every reported screening 
behavior (BSE, CBE, and mammography); scores ranged from 0-3. Results of the 
correlation are displayed in Table 7. 
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Thble 4. Reported behavior chan&es after intervention. 1990 study of breast 
cancer education for first-degree relatives. 
Behavior 
BSE 
More Careful 
More Often/regular 
Started Doing 
More Aware 
New Technique 
Total 
Clinical Exam (CBE) 
More Often/regular 
Started Program 
More Aware 
Shared Information 
Total 
Mammogram 
More Often/regular 
Started Program 
More Aware 
Asked Physician 
Total 
Number (100) 
6 
8 
3 
5 
4 
26 
5 
5 
2 
1 
13 
4 
5 
4 
3 
17 
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Table 5. Knowledge and awareness scores for emerimental and control 
groups. 1990 study of breast cancer education for first-degree relatives. 
Group 
Experimental Control 
Score Mean so Mean so t-value p 
Knowledge 1.34 .709 1.08 .794 2.31 .022* 
Awareness 3.74 .950 3.74 1.055 .00 .997 
* Significant at the p < .05 level 
Thble 6. Health Belief Model and screening behaviors. 1990 study of breast cancer 
education for first-degree relatives. 
Group 
Screened Not Screened 
Behavior Mean so Mean so t-value p 
BSE 2.82 2.92 3.38 2.25 -1.24 .221 
CBE 2.22 2.46 4.15 2.05 -5.87 .000* 
Mammogram 2.83 2.58 3.93 2.03 -3.24 .001* 
* Significant at the p < .05 level 
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Thble 7. Correlations of demographics and HBM with screening behaviors, 1990 
study of breast. cancer education for first-degree relatives. 
Variables Age Marital Status 
Age 1.000 -.193. 
Mar Stat 1.000 
Income 
Education 
Behaviors 
HBM 
* Significant at p < .01 level 
* * Significant at p < .001 level 
Income 
-.257 •• 
-.453 •• 
1.000 
Education Behaviors HBM 
-.332 •• .050 -.354 
.031 .168 .199. 
.371 •• .186. .263 •• 
1.000 -.033 .124 
1.000 .338 •• 
1.000 
The analysis revealed that there were low but significant correlations between 
demographic variables and the HBM. Age was negatively correlated with income, 
education, and the HBM. Marital status was negatively correlated with income. 
Income was positively correlated with education, behavior and the HBM, and the 
HBM was positively correlated with behaviors. The most likely predictor of breast 
cancer screening behaviors was the HBM, with income being the second. 
Based on the results of the analysis, women in the experimental group were 
significantly more likely to practice BSE than women in the control group. 
Experimental group women were also more knowledgeable about breast cancer. In 
addition, a significant correlation was demonstrated between the Health Belief Model 
for clinical breast exam and mammography, but not for breast self-exam. 
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CHAPTER V 
SUMMARY, FINDINGS, DISCUSSION, CONCLUSIONS 
AND RECOMMENDATIONS 
This chapter presents the summary of the study, conclusions, discussion of the 
results, and recommendations for further study. 
Summaty 
This study tested the effects of an educational program for first-degree relatives of 
breast cancer patients. It utilized a posttest only research design which allowed for 
random assignment of relatives to either experimental group or control group without 
the possible biases which might have been introduced with a pretest. The educational 
intervention consisted of a program where specific attention was directed to increased 
risk for breast cancer of first-degree relatives of breast cancer patients. The program 
included a packet of printed, mailed materials and a phone call from a nurse, both of 
which encouraged screening. There were two hypotheses which were tested in the 
study. Differences were considered significant if they reached or exceeded p < .05. 
H 1: There would be significant differences between the experimental group 
and the control group with participation in breast self-exam (BSE), clinical 
breast exam (CBE) or mammography activities. 
H2: There would be significant differences between the experimental group 
and the control group in awareness and knowledge of breast cancer screening. 
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Patients were recruited when they came for breast cancer treatment in either the 
Radiation Therapy unit or the Hematology/Oncology Clinic of the Bowman Gray 
School of Medicine of Wake Forest University. The patients provided personal 
information which allowed contact with a first-degree relative (either a sister, 
daughter, or mother) for participation in the project. All contact with the relatives 
was via telephone or mail. Posttest interviews were conducted approximately three 
months after the nurse's phone call (experimental group) or approximately three 
months after interviewing the patient (control group). 
Findings 
Analysis of the data produced the following tests of the hypotheses: 
1. There were statistically significant differences between the women in the 
experimental group and the women in the control group with regard to breast 
self-exam, but not with regard to clinical breast exam or mammography. 
Therefore, the first hypothesis is partially supported. 
2. There were statistically significant differences between the women in the 
experimental group and the women in the control group with regard to 
knowledge, but not in regard to awareness of breast cancer and screening. 
Therefore, the second hypothesis is partially supported. 
Discussion 
Breast cancer is a leading cause of morbidity and mortality among American 
women and there is evidence in the literature which supports the efficacy of early 
detection and treatment. In addition, there are specific risk factors which have been 
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identified, one of the strongest being a positive family history of the disease. This 
program was designed to educate and encourage these high risk women to participate 
in breast cancer screening. 
General demographic data on women at risk for breast cancer indicate that risks 
increase with age and higher socioeconomic and educational levels. Demographic 
data on both the patients and the relatives in this study reveal the population to 
consist primarily of white, middle-class, well-educated women who tend to be married. 
In addition, most of the patients were diagnosed either during or after menopause or 
post-hysterectomy. Mean years of survival since diagnosis are 4.7. This study 
population is consistent with what could be expected based on the literature. 
Published information reveals that most breast lumps are found by the woman 
herself but evidence is lacking of whether or not the woman was doing breast self-
exam (BSE) at the time she found the lump. Patients in this study revealed that most 
of them found the lumps themselves, consistent with the findings in the literature. 
Further investigation revealed that about the same numbers found the cancers while 
doing BSE or by accident. Nearly 19% (18.9%) discovered their breast lumps as a 
result of another symptom, such as pain in the breast, which prompted them to 
examine their breasts. 
While the majority of the relatives (70.5%) in this study were practicing breast 
self-exam (BSE), 46% of the study participants did not have clinical breast exams 
(CBE) as recommended by the American Cancer Society. Even more alarming for 
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this high risk group, 61.5% did not get mammograms as often as was recommended 
by the ACS. 
The theoretical basis for this study was the Health Belief Model (HBM). The 
findings in this study are consistent with the predictive value of the HBM. According 
to the HBM, the likelihood of participation in screening is a function of perceived 
susceptibility to a specific disease, perceived seriousness of the disease, perceived 
ability to participate in screening, and perceived barriers to and benefits from 
screening. The present study found that clinical breast exam (CBE) and 
mammography were predicted by the HBM, but breast self-exam (BSE) was not. 
These findings suggest that the HBM may be a better predictor of specific health 
behaviors which are practiced on an occasional basis (CBE and mammograms), than 
behaviors that need to be practiced on a continuous basis (BSE). 
Finally, correlations between the demographics, the HBM, and the total number 
of screening behaviors were examined. Although there were statistically significant 
findings, the absolute values of many significant correlations fell between .19 and .45. 
Not surprisingly, age was negatively correlated with income and education. In 
addition, younger women were more likely to express beliefs consistent with the 
HBM. Being married was negatively correlated with income, but income was 
positively correlated with education, participation in screening, and the HBM. The 
HBM was most likely correlated with participation in breast cancer screening, with 
income being second. Certainly the correlations of income with education, the Health 
Belief Model, and participation in screening were consistent with what might be 
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predicted. It was somewhat surprising to find that education had a weak negative 
correlation with behaviors and a weak positive correlation with the HBM. 
One concern of the researcher is that many women were not being screened with 
clinical breast exams or mammograms as often as is recommended and that this 
program did not alter that fact. One possible explanation is the short time frame of 
the project. While it was possible that the three-month time period may not have 
allowed enough time to take into account the "sleeper effect" whereby a process of 
attitude change must take place between the intervention and the desired action, it 
was assumed that if the women were going to participate in screening as a result of 
the intervention, they would do so within the first three months. A second three-
month follow-up study with a random sample of 45 would determine if the proportion 
of women screened would increase (power= .80, alpha =.05, expected change = 20 
percentage points) (Cohen, 1969). In addition, while few women listed actual barriers 
to screening when asked direct questions, many indicated that they were following 
their physicians' recommendations which were different from those of the American 
Cancer Society. A third explanation which cannot be ignored is that the phone calls 
revealed that these women were very busy. Some expressed the feeling that they just 
did not have time to be screened. Many of the relatives have small children, or sick 
relatives, for whom they provide some care or work two jobs, or attend both school 
and work. 
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Conclusions 
This educational program in breast cancer screening was effective in increasing 
knowledge about breast cancer and breast cancer screening. Women in the 
experimental group also reported greater participation in breast self-exam. 
Information concerning how the patients discovered their breast lumps 
emphasizes the need for continuing efforts in breast self-exam education, particularly 
in light of the fact that women in this study were not participating in either clinical 
breast exam or mammography as recommended. 
The efficacy of the Health Belief Model (HBM) as a theoretical basis for 
educational programs in breast cancer education was demonstrated. The correlation 
of the HBM with screening behaviors is encouraging for future studies. 
This researcher has no explanation for the negative correlation of educational 
level and screening behaviors. It is possible to speculate, but more practical to 
address the issue in a larger, follow-up study. The positive correlation of income with 
screening behaviors was expected since there are costs associated with both clinical 
breast exam and mammography. Women with lower incomes may feel they cannot 
afford to pay for screening, even with sliding payment scales available in the public 
health departments. 
A major concern of the researcher is the fact that these women often reported 
contacting their physicians concerning screening and were told that they did not need 
to be screened. While most of the literature suggests that mammograms not be done 
on women younger than 30 years of age, many of the women who reported asking for 
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mammograms and being refused by their physicians were greater than 40 years of 
age. Clearly, physician behavior concerning high risk women needs to b~ addressed. 
Recommendations 
The program was successful in that it resulted in higher rates of breast self-exam 
and knowledge among the experimental group women. There are, however, several 
points which should be considered in future programs. 
1. Telephone calls from the nurse were greatly appreciated by the participants in 
the study. Many expressed the same sentiment, "It's so nice to know that 
someone cares about us and how we feel." Surprisingly, the women expressed 
appreciation to both the resear~h assistant and the principal investigator for 
the posttest interview phone calls! 
2. The time frame of future studies should be lengthened to allow for those 
participants who need more time between receiving the message and taking 
action. It is suggested that one year might be an appropriate length. 
3. Future studies should include patients who receive care from community-
based oncologists and radiologists in order to reach patients who do not seek 
care in a tertiary care facility. This change would probably result in more 
minorities being enrolled in the study. 
4. Programs in breast cancer screening should include evaluation of primary 
physicians' practices for high-risk women. It is counter-productive to 
encourage women to seek screening if their primary care physicians 
discourage it. 
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5. Physicians and the ACS should reach reasonable agreements on 
recommendations for breast cancer screening in order for programs to match 
recommendations and practice. 
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APPENDIX A 
QUESTIONNAIRE FOR PATIENT 
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CONSENT FORM 
I understand that I am being asked to participate in a research project conducted 
by a faculty member of the Bowman Gray School of Medicine, who is also a doctoral 
student in the School of Education at the University of North Carolina at 
Greensboro. The study is concerned with breast cancer screening practices of close 
female relatives of breast cancer patients. 
I understand that I will be asked questions about my background and my breast 
cancer. In addition, I will be asked to supply the name of one adult, female relative 
(mother, sister, or daughter) who may be contacted as part of this study. My 
interview should take about five minutes. 
I understand that neither my name, nor the name of my relative, will ever be 
linked with the recorded responses of this interview. All responses will be completely 
anonymous. I may refuse to be interviewed, and if I decide to participate, I may 
withdraw at any time with no penalty, or loss of benefits of any kind. I further 
understand that supplying the name of a relative in no manner obligates her to 
participate in this study. 
If I have further questions about this project, I may call Penny C. Sharp (919) 
748-2129 at the Bowman Gray School of Medicine. If I have any questions about the 
rights of a research subject, I may call the Chairman of the Clinical Research 
Practices Committee at Bowman Gray (919) 748-2328. 
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All of my questions about the project have been satisfactorily answered and I 
agree to participate. 
Witness Participant 
( ) ____________ __ 
Date Participant's Phone No. 
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Appendix A 
Questionnaire for Patient 
I.D. ___ _ 
RELATIVE NAME: _____________ _ 
ADDRESS: ---------------------------------------
CITY: __________________________ _ 
STATE: ------------- ZIP: ____ __ 
PHONE:(_)-----
RELATIONSHIP: _________ _ 
BEST TIME OF DAY TO CALL: 
How old were you on your last birthday? __ _ 
What year were you diagnosed with breast cancer? ________ _ 
What is your marital status? 
_ Married _ Single _ Divorced _ Widowed Other 
What is your race? ___ Black _ White _ Other 
What was the last grade of school you completed? ___ _ 
What was your immediate family's income last year? 
a. $14,999 or below __ _ 
b. $15,000 - 24,999 -
c. $25,000 - 34,999 -
d. $35,000 or above __ _ 
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Was your breast cancer diagnosed before, during or after menopause, or post-
hysterectomy? __ _ 
How was your breast cancer discovered? ---------------
If you found the lump yourself, was it by accident of during breast self- examination? 
Have you discussed your breast cancer with the relative you named? __ _ 
Do you think your relative participates in breast self-examination? __ 
Do you think your relative goes to the doctor for clinical breast 
examinations? ----
Do you think your relative has mammography breast examinations on a regular 
basis? ---
Does anyone else in your family have breast cancer? __ _ 
If so, who? 
Sister/s yes/no 
Daughter/s yes/no 
Mother yes/no 
Aunt/s yes/no 
Niece/s yes/no 
Cousin/s yes/no 
Grandmother Is yes/no 
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APPENDIXB 
EXPERIMENTAL GROUP QUESTIONNAIRE 
CONTROL GROUP QUESTIONNAIRE 
I.D. 
Date: ----
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Appendix B 
Experimental Group Questionnaire 
Hello, this is and I am a research assistant at the -------------------
Bowman Gray School of Medicine. I would like to ask you a few questions which 
should take about 20 minutes of your time. As you may recall, you received a packet 
of materials from us about breast cancer and Karen Masten, a nurse at Bowman 
Gray called you in order to answer any questions you had about the materials or 
breast cancer. My call is the last part of the project concerning relatives of breast 
cancer patients. Did you receive the packet of materials and the phone call from Ms. 
Masten? 
Would you mind taking about 20 minutes of your time to answer some questions 
about breast cancer and your health practices? I would like to assure you that your 
answers will all be anonymous and neither your name, nor your relative's name will 
ever be linked to the results of this study. You do not have to participate and if you 
refuse, it will have no effect on your relative's treatment at Bowman Gray. 
(If refuses, reason: ) 
First I would like to ask you some questions about breast self-examination. 
1. Have you done breast self-examination in the last 3 months? Yes/No 
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When did you do the last one? ___ (month) 
2. Have you attended a class to learn BSE in the last 3 months? Yes/No 
3. How interested are you in attending a class in BSE? (1-5 scale) __ 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
4. Do you think you can perform BSE correctly? Yes/No 
5. Have you done anything differently about BSE as a result of the packet of 
information you received from us or the nurse's phone call? Yes/No 
If yes, what? ______________ _ 
If not, why? ______________ _ 
Next, I would like to ask you some questions about clinical breast examination. 
6. Have you had a physician or other health professional examine your breasts in the 
last 3 months? Yes/No 
If Yes, when? ------
(If yes, skip to 10) 
7. Have you ever had a physician examine your breasts? Yes/No 
How long ago? __ _ 
If never, why? Fear/Embarrassed/Don't need it/Don't know/Other 
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If other, what? _____________ _ 
8. Have you made a future appointment for a clinical breast examination? Yes/No 
What is your appointment date? ___ _ 
9. How interested are you in having a clinical breast exam? 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
10. Have you done anything differently about clinical breast examinati.on as a result of 
either the packet of information or the nurse's phone call? Yes/No 
If yes, what? _____________ _ 
If not, why? _____________ _ 
11. Do you think you would have any difficulty making an appointment and going to 
the doctor for a breast examination? Yes/No 
If yes, what? _________________ _ 
Now, I would like to ask you some questions about mammography. 
12. Have you had a mammogram, that is an x-ray examination of the breast tissue in 
the last three months? Yes/No 
If yes, when? ___ _ 
(if yes, skip to 17) 
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13. Have you ever had a mammogram? Yes/No 
How long ago? __ _ 
14. Have you made a future appointment for a mammogram? Yes/No 
What is your appointment date? _____ _ 
15. How interested are you in having a mammogram? __ 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
16. Do you think you would have any difficulty making an appointment for a 
mammogram and keeping the appointment? Yes/No 
If yes, why? _______________ _ 
17. Have you done anything differently about mammography as a result of either the 
packet of information or the nurse's phone call? Yes/No 
If yes, what? _____________ _ 
If not, why? _____________ _ 
Next, I would like to ask you some general questions about breast cancer. 
18. How concerned are you about breast cancer? 
1 = Not at all concerned 
2 = Slightly concerned 
3 = Uncertain 
4 = Somewhat concerned 
5 = Very concerned 
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19. How likely do you think it is that you might get breast cancer? 
1 = Not at all likely 
2 = Slightly 
3 =Unsure 
4 =Somewhat 
5 = Very likely 
20. What percent of breast cancer do you think can be cured if it is found early and 
treated correctly? % 
21. Have you ever discussed your (relative's) breast cancer with her? Yes/No 
If not, why? _______________ _ 
(If no, skip to 25) 
22. Did she encourage you to do BSE? Yes/No 
23. Did she encourage you to have a clinical breast examination? Yes/No 
24. Did she encourage you to have a mammogram? Yes/No 
I need to have some information on your background. 
25. How old were you on your last birthday? __ _ 
26. What is your marital status? 
Married 
__ Single/Separated 
Divorced 
Widowed 
Other 
27. What was your total household income last year? 
a. $14,999 or below __ 
b. $15,000- 24,999 -
c. $25,000 - 34,999 --
d. $35,000 or above __ 
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28. What was the last grade of school you completed?_ 
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(Control Group Questionnaire) 
J.D. __ _ 
Hello, my name is and I am a research assistant at the 
Bowman Gray School of Medicine. I am calling concerning a research project 
designed to learn more about women and breast cancer screening practices. I would 
like to ask you a few questions which should take about 20 minutes of your time. As 
you know, your (relative),----------'' has breast cancer and she gave 
us your name and said that we could call you concerning our project. I would like to 
assure you that your or your (relative's) names will never be connected with the 
answers which you may give me or any part of the study. We are talking to about 
200 relatives of breast cancer patients. 
Would you mind answering some questions which will take about 20 minutes of 
your time? 
(If respondent refuses, record reason: 
First I would like to ask you some questions about breast self-examination. 
1. Have you done breast self-examination in the last 3 months? Yes/No 
When did you do the last one? (month) 
2. Have you attended a class to learn BSE in the last 3 months? Yes/No 
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3. How interested are you in attending a class in BSE? (1-5 scale) __ 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
4. Do you think you can perform BSE correctly? Yes/No 
Next, I would like to ask you some questions about clinical breast examination. 
5. Have you had a physician or other health professional examine your breasts in the 
last 3 months? Yes/No 
If Yes, when? ______ _ 
(If yes, skip to 10) 
6. Have you ever had a physician examine your breasts? Yes/No 
How long ago? __ _ 
If no, why? Fear/Embarrassed/Don't need/Don't know/Other 
If other, what? ______________ _ 
7. Have you made a future appointment for a clinical breast examination? Yes/No 
What is your appointment date? ___ _ 
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8. How interested are you in having a clinical breast exam? __ 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
9. Do you think you would have any difficulty making an appointment and going to 
the doctor for a breast examination? Yes/No 
Ifyes,why? __________________________________ __ 
Now, I would like to ask you some questions about mammography. 
10. Have you had a mammogram, that is an x-ray examination of the breast tissue in 
the last three months? Yes/No 
If yes, when? ____ __ 
(If yes, skip to 15) 
11. Have you ever had a mammogram? Yes/No 
How long ago? __ _ 
If never, why? Fear/Embarrassment/Don't need/Don't know/Other 
If other, what? 
12. Have you made a future appointment for a mammogram? Yes/No 
What is your appointment date? _____ _ 
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13. How interested are you in having a mammogram? __ 
1 =Not at all 
2 = Slightly interested 
3 = Uncertain 
4 = Interested 
5 = Very interested 
14. Do you think you would have any difficulty making an appointment for a 
mammogram and keeping the appointment? Yes/No 
Ifyes,why? ______________________________ _ 
Next, I would like to ask you some general questions about breast cancer. 
15. How concerned are you about breast cancer? __ 
1 = Not at all concerned 
2 = Slightly concerned 
3 = Uncertain 
4 = Somewhat concerned 
5 = Very concerned 
16. How likely do you think it is that you might get breast cancer? __ 
1 = Not at all likely 
2 = Slightly 
3 =Unsure 
4 =Somewhat 
5 = Very likely 
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17. What percent of breast cancer do you think can be cured if it is found early and 
treated correctly? % 
18. Have you ever discussed your (relative's) breast cancer with her? Yes/No 
If not, why? _______________ _ 
(If no, skip to 22) 
19. Did she encourage you to do BSE? Yes/No 
20. Did she encourage you to have a clinical breast examination? Yes/No 
21. Did she encourage you to have a mammogram? Yes/No 
I need to have some information on your background. 
22. How old were you on your last birthday? __ _ 
23. What is your marital status? 
Married 
__ Single/Separated 
Divorced 
Widowed 
Other 
24. What was your total household income last year? 
a. $14,999 or below __ 
b. $15,000- 24,999 -
c. $25,000 - 34,999 -
d. $35,000 or above __ 
25. What was the last grade of school you completed?_ 
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APPENDIXC 
SAMPLE LE'ITER SENT TO EXPERIMENTAL GROUP 
SAMPLE LE'ITER SENT TO CONTROL GROUP 
BREAST CANCER BROCHURE FOR FIRST-DEGREE RELATIVES 
The Bowman Gray 
School of Medicine 
The Department of Family 
and Community Medicine 
(919) 748-4479 
"OParticipant Name·o·c 
·ostreet Address·o·c 
·ocity, state, Zip code·o·c 
Dear "OParticipant Name"O"C: 
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WAKE FOREST 
September 25, 1990 
I am sending you the enclosed materials about breast cancer 
screening as part of a project designed to inform women about the 
value of early detection of breast cancer. Your name was given to 
me by your ·oRelative, Name·o·c, who is receiving treatment for 
breast cancer at the Bowman Gray School of Medicine of Wake Forest 
University. 
We have learned that finding breast cancer early is very 
important and modern technology is making it easier and easier to 
do this. The three methods of screening for breast cancer are 
breast self-examination, clinical examination and mammography. The 
enclosed materials will explain more about each of these. 
In addition to these materials, you will be getting a phone 
call from a nurse who is involved with this project, Karen Masten, 
R.N., M.S.N. Karen will be calling within the next week and will 
be ready to answer any questions which you may have about breast 
cancer and screening for breast cancer. Please write down any 
questions that you may have after reading these materials so that 
she can answer them for you. 
If you have any additional questions about this project or 
about why you received this information, please feel free to call 
me collect at (919) 748-2129. If I am not in my office at the time 
of your call, I will return your call as soon as possible. 
Sincerely, 
Penny c. Sharp, M.Ed. 
Instructor in Family & Community Medicine 
·T·N·p·p 
300 South Hawthorne Road, Winston-Salem, North Carolina 27103 
TELEX 806449 BGSM WSL TELEF AX (919) 748-4204 
The Bowman Gray 
School of Medicine 
The Department of Family 
and Community Medicine 
(919) 748-4479 
·oParticipant Name·o·c 
·ostreet Address·o·c 
·ocity, state, Zip code·o·c 
Dear ·oParticipant Name·o·c: 
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WAKE FOREST 
September 25, 1990 
I am sending you the enclosed materials about breast cancer 
screening as part of the project designed to inform women about the 
value of early detection of breast cancer. As we told you during 
the telephone interview, your name was given to me by your 
·oRelative, name·o·c, who is receiving treatment for breast cancer 
at.the Bowman Gray School of Medicine of Wake Forest university. 
We have learned that finding breast cancer early is very 
important and modern technology is making it easier and easier to 
do this. The three methods of screening for breast cancer are 
breast self-examination, clinical examination and mammography. The 
enclosed materials will explain more about each of these. 
In addition to these materials, you will be getting a phone 
call from a nurse who is involved with this project, Karen Masten, 
R.N., M.S.N. Karen will be calling within the next three weeks and 
will be ready to answer any questions which you may have about 
breast cancer and screening for breast cancer. Please write down 
any questions that you may have after reading these materials so 
that she can answer them for you. 
If you have any additional questions about this project, 
please feel free to call me collect at (919) 748-2129. If I am 
not in my office at the time of your call, I will return your call 
as soon as possible. 
Sincerely, 
Penny c. Sharp, M.Ed. 
Instructor in Family & Community Medicine 
"T·N·p·p 
300 South Hawthorne Road, Winston-Salem, North Carolina 27103 
TELEX 806449 BGSM WSL TELEF AX (919) 748-4204 
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That's the bad news. 
Now for the good! 
Breast cancer can be cured! 
The sooner cancer of any kind is 
found, the better the chances are 
that if can be cured. This is true of 
breast cancer. If the breast lump is 
found early and treated about 9 out 
of every I 0 breast cancers can be 
cured. 
How can you fmd out if you have 
breast cancer? Well, there are three 
ways that you can check. 
1. Breast Self-examination: An 
examination of all of her own 
breast tissue by a woman. Be-
cause the breasts are located on 
the outside of the ribs, you can 
feel the tissue to see if there are 
any lumps which might mean 
Breast Cancer Screening 75 
\ / ,. 
. your 
.. .:: are any dif-
__.,e shape or size or if 
... nlll looks different. He or 
she will then feel your breasts, 
chest and armpits for any lumps. 
You should have this exam every 
I to 2 years until you reach 35 
years of age, then once every year. 
3. Mammogram: An x-ray exami-
nation of the breast tissue. 
Women also need to have their 
breasts examined by x-ray. This 
exam, a mammogram, uses very 
low doses of x-ray. Itis one of the 
safest and best ways to find very 
small breast lumps, while the 
cancer is the easiest 
to cure. You ,t;;' _I 
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